SAR-20347 | Interleukin Related interleukin-related.com

Product Name :
SAR-20347

Search keywords :
SAR-20347

drugId :
null

Target Vo:
Tyrosine-protein kinase 2

Target Vo Short Name :
TYK2

Moa_Name:
Tyrosine-protein kinase JAK1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sareum

Active Company_Name :
Sareum

Active Indication_Name:
Psoriasis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Galiximab MedChemExpress
Atezolizumab Immunology/Inflammation
BRAF Antibody: BRAF Antibody is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to BRAF (4E1). It can be used for WB assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts